Your browser version may not work well with NCBI's Web applications. More information here...
1: Am J Respir Crit Care Med. 2006 Nov 1;174(9):965-9; discussion 972-4.Click here to read Links
Comment in:
Am J Respir Crit Care Med. 2007 Mar 15;175(6):628; author reply 628-9.

(R)-albuterol for asthma: pro [a.k.a. (S)-albuterol for asthma: con]

Is there scientific evidence to support the replacement of the beta-agonist racemic albuterol with levalbuterol--that is, (R)-albuterol? The argument presented further refines the question as "Do we wish to continue to treat asthma with a mixture of albuterol, of which half is an agent with no known benefit--that is, (S)-albuterol--and which may exacerbate the disease?"

PMID: 17060667 [PubMed - indexed for MEDLINE]